Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-08T02:56:18.419Z Has data issue: false hasContentIssue false
  • English
  • Français

The clinical pharmacology of appetite – its relevance to psychiatry1

Published online by Cambridge University Press:  09 July 2009

Trevor Silverstone
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Psychological Medicine , Volume 13 , Issue 2 , May 1983 , pp. 251 - 253
Copyright
Copyright © Cambridge University Press 1983

References

REFERENCES

Åsberg, M., Thoren, P., Träskman, L. & Bertilsson, L. (1976). ‘Serotonin depression’ – a biochemical subgroup within the affective disorders. Science 191, 478–481.CrossRefGoogle ScholarPubMed
Carlsson, A. (1970). Amphetamine and brain catecholamines. In Amphetamines and Related Compounds (ed. Costa, E. and Garattini, S.), pp. 289–300. Raven Press: New York.Google Scholar
Checkley, S. A. (1980). Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychological Medicine 10, 35–53.CrossRefGoogle Scholar
Cookson, J. & Silverstone, T. (1981). A double-blind comparative clinical trial of pimozide and chlorpromazine in mania: a test of the dopamine hypothesis. Acta Psychiatrica Scandinavica 64, 381–392.CrossRefGoogle Scholar
Fawcett, J. & Siomopoulos, V. (1971). Dextroamphetamine response as a possible predictor of improvement with tricyclic therapy in depression. Archives of General Psychiatry 25, 247–253.CrossRefGoogle Scholar
Gaind, R. (1969). Fenfluramine (Ponderax) in the treatment of obese psychiatric outpatients. British Journal of Psychiatry 115, 963–964.CrossRefGoogle Scholar
Garattini, S., Buczko, W., Jori, A. & Samanin, R. (1975). The mechanism of action of fenfluramine. Postgraduate Medical Journal 51, 27–35.Google ScholarPubMed
Goldberg, S., Halmi, K., Eckert, E., Casper, R. & Davis, J. (1979). Cyproheptadine in anorexia nervosa. British Journal of Psychiatry 134, 67–70.CrossRefGoogle ScholarPubMed
Gottfries, C. G. (1981). Influence of depression and antidepressants on weight. Acta Psychiatrica Scandinavica 63 (Supplement 290), 353–356.CrossRefGoogle Scholar
Holmstrand, J. & Jonsson, J. (1975). Subjective effects of two anorexigenic agents – fenfluramine and AN 488– in normal subjects. Postgraduate Medical Journal 51, 183–186.Google Scholar
Kiloh, L., Neilson, M. & Andrews, G. (1974). Response of depressed patients to methylamphetamine. British Journal of Psychiatry 125, 469–499.CrossRefGoogle ScholarPubMed
Lewis, A. (1934). Melancholia: a clinical survey of depressive states. Journal of Mental Science 80, 277–378.CrossRefGoogle Scholar
Maj, A., Lewandowska, A. & Rawton, A. (1979). Central serotonin action of amitriptyline. Pharmakopsychiatry 12, 281–285.CrossRefGoogle ScholarPubMed
Paykel, E., Muller, P. & de la, Vergue P. (1973). Amitriptyline, weight gain and carbohydrate craving: a side effect. British Journal of Psychiatry 123, 501–502.CrossRefGoogle ScholarPubMed
Robinson, R., McHugh, P. & Folstein, M. (1975). Measurement of appetite disturbance in psychiatric disorders. Journal of Psychiatric Research 12, 59–68.CrossRefGoogle ScholarPubMed
Russell, G. (1960). Body weight and balance of water, sodium and potassium in depressed patients given ECT. Clinical Science 19, 327–336.Google Scholar
Silverstone, T. (1979). Psychopharmacology of manic-depressive illness. In Current Themes in Psychiatry, Vol. 2 (ed. Gaind, R. and Hudson, B.), pp. 271–282. Macmillan: London.CrossRefGoogle Scholar
Silverstone, T. & Wells, B.. (1980). Clinical psychopharmacology of amphetamine and related compounds. In Amphetamine and Related Compounds (ed. Caldwell, J.), pp. 148–159. CRC Press: New York.Google Scholar
Silverstone, T., Fincham, J., Wells, B. & Kyriakides, M. (1980). The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man. Neuropharmacology 19, 1235–1237.CrossRefGoogle ScholarPubMed
Silverstone, T., Wells, B. & Trenchard, E. (1983). Differential dose–response effects of dexamphetamine sulphate on hunger, mood and arousal in human volunteers. Psychopharmacology (in the press).CrossRefGoogle Scholar
Smith, R. & Davis, J. (1977). Comparative effects of d−amphetamine, I-amphetamine and methylphenidate in mood in man. Psychopharmacology 53, 1–10.CrossRefGoogle Scholar
Steel, J. & Briggs, M. (1972). Withdrawal depression in obese patients after fenfluramine treatment. British Medical Journal iii, 26–27.CrossRefGoogle Scholar
Szmukler, G. (1982). Drug treatment and anorexic states. In Drugs and Appetite (ed. Silverstone, T.), pp. 159–181. Academic Press: London.Google Scholar
Van Kammen, D. & Murphy, D. (1975). Attenuation of the euphoriant and activating effects of d− and I−amphetamine by lithium carbonate treatment. Psychopharmacology 44, 215–225.CrossRefGoogle Scholar
Vendsborg, P. B., Bech, P. & Rafaelaen, O. J. (1976). Lithium treatment and weight gain. Acta Psychiatrica Scandinavica 53. 139–147.CrossRefGoogle ScholarPubMed